Latest News about PDSB
Recent news which mentions PDSB
From Benzinga
From Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
From Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
From Benzinga
From Benzinga
From Benzinga
PDS Biotechnology Earnings Conference Call Is Coming Up, Here's What You Need To Know
March 24, 2022
Tickers
PDSB
From Benzinga
Earnings Scheduled For March 23, 2022
March 23, 2022
From Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 30, 2021
From Benzinga
This Company Says It's One Step Closer to Transforming Cancer Treatment with its Latest Groundbreaking Immunotherapy
November 11, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial
October 21, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 21, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.